June Lanoue sits down with Dr. Deepu Madduri, Research & Development Leader, Johnson & Johnson Innovative Medicine, to discuss the evolving impact of women in hematology. Through personal stories and reflections, Dr. Madduri and June will share insights from their work with the WoMMen in Hematology program, including highlights from the December event at the ASH annual meeting. Together, they will explore how mentorship and diversity are shaping the future of hematology and driving meaningful innovation. 

Cynthia Accuosti Jones speaks with Heidi and Pierre Onda, co-founders of The White Ribbon Project, about the personal story behind the Project, the impact of lung cancer misconceptions, and the importance of creating a more inclusive and supportive community for those affected by the disease.

In this episode of Take 10, Donna Hodge speaks with Bill K., a retired engineer from Missouri who is living with multiple myeloma, about the importance of self-advocacy and joint decision-making in multiple myeloma care. 

In this episode of Take 10, Tracy Ely interviews Nick Barkemeyer, a physician's assistant at Tennessee Oncology specializing in multiple myeloma, about Advanced Practice Providers' (APPs) crucial role in cancer care and the importance of the Make It HAPPen™ campaign, an initiative providing APPs with tailored resources and support to improve multiple myeloma outcomes. Learn more about the Make It HAPPen™ campaign here: MakeItHAPPenMM.com 

Chumi Khurana sits down with Victoria Wolodzko Smart, Senior Vice President of Mission at Susan G. Komen, to discuss Johnson & Johnson’s partnership with the organization. Together, they aim to educate around the link between genetic mutations and prostate cancer risk, and the crucial role of awareness and early intervention in prostate cancer management.   Learn more at https://www.brcainmen.com/. 

Imran Khan, MD, PhD, and Luca Dezzani, MD, share key insights from ASCO 2024. Discover the impact of these pivotal meetings on cancer care, and the importance of bridging the gap between health and care to better support the totality of the patient.

In this episode of the Take 10 podcast, Biljana Naumovic speaks with Dr. Ashish Kamat, MBBS, about the landscape of bladder cancer care. They discuss prevailing needs, recent advancements, and the importance of patient-centric care.

In this episode of Take 10, Tyrone Brewer speaks with Stephanie Chuang, founder of The Patient Story, about the importance of making cancer care more personal — and how elevating patient voices can break down barriers, foster empathy, and empower patients to be their own best advocates.  

In this episode of the Take 10 podcast, J&J's Chumi Khurana, Vice President of U.S. Marketing and Sales, Solid Tumor, June Lanoue, Vice President of U.S. Marketing and Sales, Hematology, and Tracy Ely, Vice President of Oncology Portfolio Strategy & Execution, are “taking over” Take 10 in honor of International Women’s Day to discuss the experiences and challenges faced by women in the healthcare and oncology field, and how mentorship and support networks have helped them grow in their careers. 

In this episode of the Take 10 podcast, Tyrone Brewer speaks with Kris Bennett, Director of Health Equity at ZERO Prostate Cancer, about the work being done to increase awareness of disparities in prostate cancer and the importance of preventative health action.

In Episode 7 of the Take 10 podcast, Tyrone Brewer sits down with Meredith Unger, Vice President of U.S. Oncology Marketing and Operations, CAR-T, to discuss the benefits of exercise from a business perspective, and on a more individual level, how playing sports has helped both Tyrone and Meredith perform better as leaders throughout their careers.

In this episode of the Take 10 podcast, Tyrone Brewer will speak with caregiver and advocate, Rhonda Meckstroth. By discussing Rhonda's personal journey, her unwavering determination, and her invaluable insights, this episode underscores the vital role that caregivers play in their loved one’s cancer journeys, and the need for continued innovation in lung cancer.

In this special ESMO episode, Tyrone sits down with Luca Dezzani, Vice President of U.S. Oncology Medical Affairs, Solid Tumor, ahead of European Society of Medical Oncology's (ESMO) annual meeting to discuss the cutting-edge innovations that have us most excited.

September represents both Prostate Cancer Awareness Month and Blood Cancer Awareness Month, two areas where J&J Oncology is highly committed to reimaging care so that patients can redefine living. In this "Special Edition" Take 20 episode, Tyrone speaks with his J&J colleagues, Chumi Khurana, Vice President of U.S. Marketing and Sales, Solid Tumor, and June Lanoue, Vice President of U.S. Marketing and Sales, Hematology. The team discusses the importance of going beyond traditional “awareness” and while exploring the progress being made as an industry to address these conditions and the treatment paradigms, as well as efforts to overcome health inequities when it comes to diagnosis and treatment.

In the third episode, Tyrone and Jackie Kheene-Miron, National Director of the Oncology Clinical Educator (OCE) Team, shine a spotlight on the invaluable role oncology nurses play caring for people with cancer, and touch on the challenges they face today, as well as how J&J's clinical oncology educators are partnering with oncology nurses.

In our second episode, Tyrone speaks with Imran Khan, Vice President of US Hematology Medical Affairs, about the historic disease landscape of multiple myeloma. The pair will touch on recent advancements that have redefined care for patients as well as the work Janssen is doing to support patients and address critical issues within multiple myeloma, resulting in improved patient outcomes and earlier detection rates.

In our inaugural episode, Tyrone speaks with patient advocate Jenny Ahlstrom, founder of HealthTree Foundation, a tech platform that helps bring the patient community together. The two discuss the key role that patients play not only in their own care journey, but in the industry’s search to treat their disease.